Farokhzad, Omid C.
Harvard Medical School,
United States
2024 Rank: 7005
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Organic Chemistry
Rank in SubField 1: 112 out of 135958 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7005 | 7843 |
| Total Cites | 61802 | 65388 |
| H-index | 108 | 113 |
| Hm-index | 27 | 27 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 104 | 112 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 6029 | 6326 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 39773 | 41807 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 43774 | 44861 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.46 |
| Self-Citation Percentage |
5.48%
|
|
Farokhzad, Omid C.
Seer, Inc.,
United States
2023 Rank: 7385
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Organic Chemistry
Rank in SubField 1: 110 out of 117692 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7385 | 8283 |
| Total Cites | 55878 | 59236 |
| H-index | 101 | 105 |
| Hm-index | 26 | 26 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 93 | 101 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 5715 | 6010 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 36316 | 38272 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 39259 | 40262 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.47 |
| Self-Citation Percentage |
5.67%
|
|
Farokhzad, Omid C.
Seer, Inc.,
United States
2022 Rank: 7932
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Organic Chemistry
Rank in SubField 1: 107 out of 103235 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7932 | 8770 |
| Total Cites | 48834 | 51909 |
| H-index | 94 | 97 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 87 | 95 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 5312 | 5606 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 32008 | 33860 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 34148 | 35059 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.48 |
| Self-Citation Percentage |
5.92%
|
|
Farokhzad, Omid C.
Harvard Medical School,
United States
2021 Rank: 8218
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 102 out of 89177 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8218 | 9147 |
| Total Cites | 45697 | 48296 |
| H-index | 92 | 94 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 80 | 88 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 5105 | 5390 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 30326 | 31921 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 31931 | 32688 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.48 |
| Self-Citation Percentage |
5.38%
|
|
Farokhzad, Omid C.
Brigham and Women's Hospital,
United States
2020 Rank: 9922
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 123 out of 75210 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9922 | 10818 |
| Total Cites | 37670 | 40036 |
| H-index | 81 | 86 |
| Hm-index | 22 | 22 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 67 | 75 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 4611 | 4896 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 25142 | 26635 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 26235 | 26920 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.49 |
| Self-Citation Percentage |
5.91%
|
|
Related Profiles
Featured Profiles
Partner with Us
📢 Reach a targeted audience of science enthusiasts and professionals through our platform. Contact our marketing team:
business@topscinet.com cc: top2percentscientist@gmail.comGet a custom proposal tailored to your banner ad goals.
Partner with Us
📢 Partner with us and reach a targeted audience of science enthusiasts and professionals through our platform. Your company/institute’s banner could be here.